ClearPoint Neuro Inc vs Toyota Motor Corp — how do they compare? ClearPoint Neuro Inc trades at $14.92 (market cap $444.14M), while Toyota Motor Corp trades at $189.04 (market cap $223.57B). The key difference: Toyota Motor Corp is far larger — about 503.4× ClearPoint Neuro Inc's market cap, and Toyota Motor Corp pays a 3.32% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | TM | |
|---|---|---|
Market Cap | $444.14M | $223.57B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.60 | $248.29 |
52-Week Low | $8.66 | $166.50 |
Enterprise Value | $478.72M | $417.39B |
Dividend Yield | — | 3.32% |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $14.21, up 6.12% today, amid mixed technical signals and challenging fundamentals. The company reported Q2 2026 revenue growth but missed earnings expectations with a loss of $0.38 per share, continuing a trend of negative profitability. Despite 100% analyst buy ratings, financial metrics show significant losses with a net income margin of -81.76% and negative cash flow from operations of $30 million projected for 2026.
The investment case hinges on regulatory progress and partnership developments in neurotechnology, but substantial execution risks and persistent losses present headwinds. While analyst consensus remains bullish on long-term potential, current financial performance suggests cautious optimism is warranted until profitability improves.
Toyota Motor (TM) trades at $190.09, up 1.39% with bullish technical signals and strong fundamentals. The stock shows robust earnings beats in recent quarters with Q2 2026 EPS of $7.57 exceeding expectations by 62%. Valuation remains attractive with P/E of 8.48 and P/B of 0.95, while revenue growth continues at $48.04T for 2025. Technical indicators show bullish moving averages and support at $189.
Outlook remains positive given strong hybrid vehicle demand and raised earnings guidance, though risks include China sales weakness and recall-related costs. Analyst consensus leans cautious with 62.5% hold ratings despite no sell recommendations. The stock presents value opportunity with solid cash flow generation and market leadership position.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →